WE TAKE MEDICINE PERSONALLY



Trademark Coverage

No Class Specified

Pharmaceuticals and pharmacogenetic applications of those pharmaceuticals, namely, cardiovascular pharmaceuticals, dermatological pharmaceuticals, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, ocular pharmaceuticals, pharmaceutical anti-allergic preparations and substances, pharmaceuticals for the treatment of erectile dysfunction, pharmaceutical preparations for anticoagulants, pharmaceutical preparations for antidepressants, pharmaceutical preparations for appetite suppressants, pharmaceutical preparations for the treatment of gout, pharmaceutical preparations for the treatment of heart rhythm disorders, pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents, pharmaceutical preparations acting on the central nervous system, pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases, pharmaceutical preparations for the inhalation treatment of pulmonary hypertension, pharmaceutical preparations for ocular or intraocular surgery, pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis, pharmaceutical preparations for treating allergic rhinitis and asthma, pharmaceutical preparations for treating diabetes, pharmaceutical preparations for treating skin disorders, pharmaceutical preparations for treating wounds, pharmaceutical preparations for use in dermatology, pharmaceutical preparations for use in urology, pharmaceutical products for ophthalmological use, pharmaceutical preparations for the treatment of bone diseases, pharmaceutical preparations for the treatment of respiratory diseases and asthma, pharmaceuticals, namely, lipid-lowering agents, pharmaceuticals, namely, psychotropics, pharmaceuticals for the treatment of fatigue, and pharmaceuticals for the treatment of autism

Owner
Timeline
  • May 07
    2012
    Abandonment Notice Mailed No Use Statement Filed
  • May 07
    2012
    Abandonment No Use Statement Filed
  • Sep 24
    2011
    Notice Of Approval Of Extension Request Mailed
  • Sep 23
    2011
    Extension 5 Granted
  • Sep 21
    2011
    Extension 5 Filed
  • Sep 21
    2011
    TEAS Extension Received
  • Mar 22
    2011
    Notice Of Approval Of Extension Request Mailed
  • Mar 20
    2011
    Extension 4 Granted
  • Mar 14
    2011
    Extension 4 Filed
  • Mar 14
    2011
    TEAS Extension Received
  • Sep 28
    2010
    Notice Of Approval Of Extension Request Mailed
  • Sep 27
    2010
    Extension 3 Granted
  • Sep 24
    2010
    Extension 3 Filed
  • Sep 24
    2010
    TEAS Extension Received
  • Apr 13
    2010
    Notice Of Approval Of Extension Request Mailed
  • Apr 12
    2010
    Extension 2 Granted
  • Mar 17
    2010
    Extension 2 Filed
  • Apr 12
    2010
    Case Assigned To Intent To Use Paralegal
  • Mar 17
    2010
    TEAS Extension Received
  • Oct 08
    2009
    Extension 1 Granted
  • Sep 25
    2009
    Extension 1 Filed
  • Oct 08
    2009
    Case Assigned To Intent To Use Paralegal
  • Sep 25
    2009
    TEAS Extension Received
  • Apr 07
    2009
    NOA Mailed SOU Required From Applicant
  • Feb 26
    2009
    Changes/Corrections After PUB Approval Entered
  • Feb 20
    2009
    Extension Of Time To Oppose Process Terminated
  • Nov 10
    2008
    TEAS Post Publication Amendment Received
  • Oct 07
    2008
    Extension Of Time To Oppose Received
  • Oct 07
    2008
    Published For Opposition
  • Sep 17
    2008
    Notice Of Publication
  • Sep 04
    2008
    Law Office Publication Review Completed
  • Sep 04
    2008
    Assigned To LIE
  • Aug 26
    2008
    Attorney Revoked And/Or Appointed
  • Aug 26
    2008
    TEAS Revoke/Appoint Attorney Received
  • Aug 27
    2008
    Examiners Amendment Mailed
  • Aug 26
    2008
    Approved For PUB Principal Register
  • Aug 26
    2008
    Examiner's Amendment Entered
  • Aug 26
    2008
    Examiners Amendment Written
  • Aug 13
    2008
    TEAS/Email Correspondence Entered
  • Aug 12
    2008
    Correspondence Received In Law Office
  • Aug 12
    2008
    TEAS Response To Office Action Received
  • Feb 12
    2008
    Priority Action Mailed
  • Feb 12
    2008
    Priority Action Written
  • Feb 11
    2008
    Assigned To Examiner
  • Nov 02
    2007
    New Application Entered In TRAM